SBIR/STTR Research Award

RAPID BIORESORBABLE Na2O-K2O-CaO-B2O3-P2O5 GLASSES

Award identifier ece7feae262bc47713945cee8aa762aa3b7bfdfff55314450faa8e0aade2f27bAwarding agency Department of Defense · Defense Health Agency

Award amount

$249,998

Program and phase

STTR · Phase I

Award year

2022

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Defense
Branch
Defense Health Agency
Recipient company
Saxon Glass Technologies, Inc.
Proposal award date
2022-04-04
Contract end date
2022-09-03
UEI
UN9RJZGMEQA3
Solicitation number
21.C
Topic code
DHA21C-001

Research abstract

This Phase I proposal in research partnership with Rutgers the State University aims to explore the range of inorganic glass systems which are dissolvable in saline solutions at human body temperatures. Glasses in the Na2O-K2O-CaO-B2O3-P2O5 system with varying Na2O/K2O/CaO and B2O3/P2O5 will be melted. Glass substrates will be made which will be subjected to varying phase separation treatments in order to develop liquid-liquid metastable immiscibility similar to the well-known Na2O-B2O3-SiO2 glass system. Glasses will be characterized for formability, crystallization, and separation into submicron-sized droplet-phase or spinodally decomposed intertwined phases. The phase-separated microstructures will be studied for their dissolution rates in saline solution. The aim is to develop microstructures where differential solubility will cause dissolution/disintegration within 1/4 - 1 hour by exceeding rigidity percolation limit. Glass technology processes to obtain stent sizes used for photochemical tissue bonding in partnership with Harvard MGH (prior AFOSR awardee) to perform animal studies and preparation for steps to commercialize the technology will be Phase II focus. It is hoped that the technology will disruptively change how luminal support is provided to blood vessels anastomosis with patency and reduced risk of vascular thrombosis.

Technology keywords

Not reported

Other awards by this recipient

Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.

Awards with the same topic code

Verified by an exact topic code match. This is not a text-similarity match.

Research funding history

2 SBIR/STTR records share this UEI (2022–2023). Reported award amounts total $1,349,944. Reported amounts are not federal obligations.

Phases: Phase II, Phase I

Agencies: Department of Defense

Agency intelligence

Department of Defense

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.